CXCR4 and glioma: Representatively, the chemoattractant molecules responsible for the myeloid cell migration to the glioma, for example, CSF-1R, avβ3/5 integrins, and CXCR4 are being targeted in multiple trials (Russo and Cappoli, 2018; Roesch et al., 2018).